OBJECTIVE: The objective of the study was to evaluate LINE-1 methylation as an intermediate biomarker for the effect of folate and vitamin B12 on the occurrence of higher grades of cervical intraepithelial neoplasia (CIN ≥ 2). METHODS: This study included 376 women who tested positive for high-risk human papillomaviruses and were diagnosed with CIN ≥ 2 (cases) or CIN ≤ 1 (non-cases). CIN ≥ 2 (yes/no) was the dependent variable in logistic regression models that specified the degree of LINE-1 methylation of peripheral blood mononuclear cells (PBMCs) and of exfoliated cervical cells (CCs) as the independent predictors of primary interest. In analyses restricted to non-cases, PBMC LINE-1 methylation (≥ 70% versus <70%) and CC LINE-1 methylation (≥ 54% versus <54%) were the dependent variables in logistic regression models that specified the circulating concentrations of folate and vitamin B12 as the primary independent predictors. RESULTS: Women in the highest tertile of PBMC LINE-1 methylation had 56% lower odds of being diagnosed with CIN ≥ 2 (odds ratio 0.44, 95% confidence interval 0.24-0.83, P = 0.011), whereas there was no significant association between degree of CC LINE-1 methylation and CIN ≥ 2 (odds ratio 0.86, 95% confidence interval 0.51-1.46, P = 0.578). Among non-cases, women with supraphysiologic concentrations of folate (>19.8 ng/mL) and sufficient concentrations of plasma vitamin B12 (≥ 200.6 ng/mL) were significantly more likely to have highly methylated PBMCs compared with women with lower folate and lower vitamin B12 (odds ratio 3.92, 95% confidence interval 1.06-14.52, P = 0.041). None of the variables including folate and vitamin B12 were significantly associated with CC LINE-1 methylation. CONCLUSION: These results suggest that a higher degree of LINE-1 methylation in PBMCs, a one-carbon nutrient-related epigenetic alteration, is associated with a lower risk of developing CIN.
OBJECTIVE: The objective of the study was to evaluate LINE-1 methylation as an intermediate biomarker for the effect of folate and vitamin B12 on the occurrence of higher grades of cervical intraepithelial neoplasia (CIN ≥ 2). METHODS: This study included 376 women who tested positive for high-risk human papillomaviruses and were diagnosed with CIN ≥ 2 (cases) or CIN ≤ 1 (non-cases). CIN ≥ 2 (yes/no) was the dependent variable in logistic regression models that specified the degree of LINE-1 methylation of peripheral blood mononuclear cells (PBMCs) and of exfoliated cervical cells (CCs) as the independent predictors of primary interest. In analyses restricted to non-cases, PBMC LINE-1 methylation (≥ 70% versus <70%) and CC LINE-1 methylation (≥ 54% versus <54%) were the dependent variables in logistic regression models that specified the circulating concentrations of folate and vitamin B12 as the primary independent predictors. RESULTS:Women in the highest tertile of PBMC LINE-1 methylation had 56% lower odds of being diagnosed with CIN ≥ 2 (odds ratio 0.44, 95% confidence interval 0.24-0.83, P = 0.011), whereas there was no significant association between degree of CC LINE-1 methylation and CIN ≥ 2 (odds ratio 0.86, 95% confidence interval 0.51-1.46, P = 0.578). Among non-cases, women with supraphysiologic concentrations of folate (>19.8 ng/mL) and sufficient concentrations of plasma vitamin B12 (≥ 200.6 ng/mL) were significantly more likely to have highly methylated PBMCs compared with women with lower folate and lower vitamin B12 (odds ratio 3.92, 95% confidence interval 1.06-14.52, P = 0.041). None of the variables including folate and vitamin B12 were significantly associated with CC LINE-1 methylation. CONCLUSION: These results suggest that a higher degree of LINE-1 methylation in PBMCs, a one-carbon nutrient-related epigenetic alteration, is associated with a lower risk of developing CIN.
Authors: Chandrika J Piyathilake; Maurizio Macaluso; Ronald D Alvarez; Walter C Bell; Douglas C Heimburger; Edward E Partridge Journal: Cancer Prev Res (Phila) Date: 2009-06-19
Authors: Chandrika J Piyathilake; Suguna Badiga; Edmond K Kabagambe; Andres Azuero; Ronald D Alvarez; Gary L Johanning; Edward E Partridge Journal: Cancer Prev Res (Phila) Date: 2012-01-18
Authors: Paula L Hyland; Laura S Burke; Ruth M Pfeiffer; Lisa Mirabello; Margaret A Tucker; Alisa M Goldstein; Xiaohong R Yang Journal: Melanoma Res Date: 2013-02 Impact factor: 3.599
Authors: Ying Gao; Keith Killian; Hong Zhang; Kai Yu; Qi-Zhai Li; Stephanie Weinstein; Jarmo Virtamo; Margaret Tucker; Philip Taylor; Demetrius Albanes; Paul Meltzer; Neil Caporaso Journal: World J Gastrointest Oncol Date: 2012-08-15
Authors: Chandrika J Piyathilake; Nicholas J Ollberding; Ranjit Kumar; Maurizio Macaluso; Ronald D Alvarez; Casey D Morrow Journal: Cancer Prev Res (Phila) Date: 2016-03-02
Authors: Lauren E McCullough; Jia Chen; Alexandra J White; Xinran Xu; Yoon Hee Cho; Patrick T Bradshaw; Sybil M Eng; Susan L Teitelbaum; Mary Beth Terry; Gail Garbowski; Alfred I Neugut; Hanina Hibshoosh; Regina M Santella; Marilie D Gammon Journal: J Cancer Date: 2015-05-01 Impact factor: 4.207
Authors: Chandrika J Piyathilake; Suguna Badiga; Ronald D Alvarez; Edward E Partridge; Gary L Johanning Journal: PLoS One Date: 2013-01-24 Impact factor: 3.240